# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-24-051958
Filing Date
2024-04-25
Accepted
2024-04-25 16:05:27
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tm242684d4_ars.pdf | ARS | 1820403
| Complete submission text file | 0001104659-24-051958.txt |  | 2506786

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-15006 | Film No.: 24876200
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)